 | • レポートコード：GIR-105X01031 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗消化性潰瘍薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗消化性潰瘍薬の種類別市場規模（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬）、用途別市場規模（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗消化性潰瘍薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eisai、Daewoong Pharmaceutical、Takeda Pharmaceutical、HeliCure、AstraZeneca、Ore Pharmaceuticals、Sihuan Pharmaceutical、GlaxoSmithKline、Pfizer、Abbott Laboratories、Yuhan Corporation、Cadila Healthcare、Boehringer Ingelheim ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬 ・用途別分析2016年-2026年：胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD） ・抗消化性潰瘍薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗消化性潰瘍薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗消化性潰瘍薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗消化性潰瘍薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗消化性潰瘍薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti Peptic Ulcer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti Peptic Ulcer Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anti Peptic Ulcer Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anti Peptic Ulcer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs
Market segment by Application can be divided into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
The key market players for global Anti Peptic Ulcer Drugs market are listed below:
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Pharmaceuticals
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti Peptic Ulcer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti Peptic Ulcer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Antibiotics
1.2.7 Ulcer Protective Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti Peptic Ulcer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Global Anti Peptic Ulcer Drugs Market Size & Forecast
1.4.1 Global Anti Peptic Ulcer Drugs Sales in Value (2016-2026))
1.4.2 Global Anti Peptic Ulcer Drugs Sales in Volume (2016-2026)
1.4.3 Global Anti Peptic Ulcer Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Anti Peptic Ulcer Drugs Production Capacity Analysis
1.5.1 Global Anti Peptic Ulcer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Anti Peptic Ulcer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti Peptic Ulcer Drugs Market Drivers
1.6.2 Anti Peptic Ulcer Drugs Market Restraints
1.6.3 Anti Peptic Ulcer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Eisai Details
2.1.2 Eisai Major Business
2.1.3 Eisai Anti Peptic Ulcer Drugs Product and Services
2.1.4 Eisai Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Daewoong Pharmaceutical
2.2.1 Daewoong Pharmaceutical Details
2.2.2 Daewoong Pharmaceutical Major Business
2.2.3 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product and Services
2.2.4 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Takeda Pharmaceutical
2.3.1 Takeda Pharmaceutical Details
2.3.2 Takeda Pharmaceutical Major Business
2.3.3 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product and Services
2.3.4 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 HeliCure
2.4.1 HeliCure Details
2.4.2 HeliCure Major Business
2.4.3 HeliCure Anti Peptic Ulcer Drugs Product and Services
2.4.4 HeliCure Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Anti Peptic Ulcer Drugs Product and Services
2.5.4 AstraZeneca Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Ore Pharmaceuticals
2.6.1 Ore Pharmaceuticals Details
2.6.2 Ore Pharmaceuticals Major Business
2.6.3 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Product and Services
2.6.4 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sihuan Pharmaceutical
2.7.1 Sihuan Pharmaceutical Details
2.7.2 Sihuan Pharmaceutical Major Business
2.7.3 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product and Services
2.7.4 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Anti Peptic Ulcer Drugs Product and Services
2.8.4 GlaxoSmithKline Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Anti Peptic Ulcer Drugs Product and Services
2.9.4 Pfizer Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business
2.10.3 Abbott Laboratories Anti Peptic Ulcer Drugs Product and Services
2.10.4 Abbott Laboratories Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Yuhan Corporation
2.11.1 Yuhan Corporation Details
2.11.2 Yuhan Corporation Major Business
2.11.3 Yuhan Corporation Anti Peptic Ulcer Drugs Product and Services
2.11.4 Yuhan Corporation Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Cadila Healthcare
2.12.1 Cadila Healthcare Details
2.12.2 Cadila Healthcare Major Business
2.12.3 Cadila Healthcare Anti Peptic Ulcer Drugs Product and Services
2.12.4 Cadila Healthcare Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Anti Peptic Ulcer Drugs Product and Services
2.13.4 Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti Peptic Ulcer Drugs Sales by Manufacturer
3.1 Global Anti Peptic Ulcer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti Peptic Ulcer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti Peptic Ulcer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti Peptic Ulcer Drugs Manufacturer Market Share
3.4.2 Top 6 Anti Peptic Ulcer Drugs Manufacturer Market Share
3.5 Global Anti Peptic Ulcer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti Peptic Ulcer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti Peptic Ulcer Drugs Market Size by Region
4.1.1 Global Anti Peptic Ulcer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Anti Peptic Ulcer Drugs Revenue by Region (2016-2026)
4.2 North America Anti Peptic Ulcer Drugs Revenue (2016-2026)
4.3 Europe Anti Peptic Ulcer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Anti Peptic Ulcer Drugs Revenue (2016-2026)
4.5 South America Anti Peptic Ulcer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Anti Peptic Ulcer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti Peptic Ulcer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Anti Peptic Ulcer Drugs Revenue by Type (2016-2026)
5.3 Global Anti Peptic Ulcer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti Peptic Ulcer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Anti Peptic Ulcer Drugs Revenue by Application (2016-2026)
6.3 Global Anti Peptic Ulcer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti Peptic Ulcer Drugs Sales by Type (2016-2026)
7.2 North America Anti Peptic Ulcer Drugs Sales by Application (2016-2026)
7.3 North America Anti Peptic Ulcer Drugs Market Size by Country
7.3.1 North America Anti Peptic Ulcer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Anti Peptic Ulcer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti Peptic Ulcer Drugs Sales by Type (2016-2026)
8.2 Europe Anti Peptic Ulcer Drugs Sales by Application (2016-2026)
8.3 Europe Anti Peptic Ulcer Drugs Market Size by Country
8.3.1 Europe Anti Peptic Ulcer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti Peptic Ulcer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti Peptic Ulcer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Anti Peptic Ulcer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Anti Peptic Ulcer Drugs Market Size by Region
9.3.1 Asia-Pacific Anti Peptic Ulcer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti Peptic Ulcer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti Peptic Ulcer Drugs Sales by Type (2016-2026)
10.2 South America Anti Peptic Ulcer Drugs Sales by Application (2016-2026)
10.3 South America Anti Peptic Ulcer Drugs Market Size by Country
10.3.1 South America Anti Peptic Ulcer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Anti Peptic Ulcer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Anti Peptic Ulcer Drugs Market Size by Country
11.3.1 Middle East & Africa Anti Peptic Ulcer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti Peptic Ulcer Drugs Typical Distributors
12.3 Anti Peptic Ulcer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti Peptic Ulcer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti Peptic Ulcer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Eisai Basic Information, Manufacturing Base and Competitors
Table 4. Eisai Major Business
Table 5. Eisai Anti Peptic Ulcer Drugs Product and Services
Table 6. Eisai Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Daewoong Pharmaceutical Major Business
Table 9. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product and Services
Table 10. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Pharmaceutical Major Business
Table 13. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product and Services
Table 14. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. HeliCure Basic Information, Manufacturing Base and Competitors
Table 16. HeliCure Major Business
Table 17. HeliCure Anti Peptic Ulcer Drugs Product and Services
Table 18. HeliCure Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Anti Peptic Ulcer Drugs Product and Services
Table 22. AstraZeneca Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Ore Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Ore Pharmaceuticals Major Business
Table 25. Ore Pharmaceuticals Anti Peptic Ulcer Drugs Product and Services
Table 26. Ore Pharmaceuticals Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sihuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Sihuan Pharmaceutical Major Business
Table 29. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product and Services
Table 30. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline Major Business
Table 33. GlaxoSmithKline Anti Peptic Ulcer Drugs Product and Services
Table 34. GlaxoSmithKline Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Anti Peptic Ulcer Drugs Product and Services
Table 38. Pfizer Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Abbott Laboratories Major Business
Table 41. Abbott Laboratories Anti Peptic Ulcer Drugs Product and Services
Table 42. Abbott Laboratories Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Yuhan Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Yuhan Corporation Major Business
Table 45. Yuhan Corporation Anti Peptic Ulcer Drugs Product and Services
Table 46. Yuhan Corporation Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 48. Cadila Healthcare Major Business
Table 49. Cadila Healthcare Anti Peptic Ulcer Drugs Product and Services
Table 50. Cadila Healthcare Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 52. Boehringer Ingelheim Major Business
Table 53. Boehringer Ingelheim Anti Peptic Ulcer Drugs Product and Services
Table 54. Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Anti Peptic Ulcer Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Anti Peptic Ulcer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Anti Peptic Ulcer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Anti Peptic Ulcer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Anti Peptic Ulcer Drugs Production Site of Key Manufacturer
Table 60. Global Anti Peptic Ulcer Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Global Anti Peptic Ulcer Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Global Anti Peptic Ulcer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Anti Peptic Ulcer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Anti Peptic Ulcer Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Global Anti Peptic Ulcer Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Global Anti Peptic Ulcer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Anti Peptic Ulcer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Anti Peptic Ulcer Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 69. Global Anti Peptic Ulcer Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 70. Global Anti Peptic Ulcer Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. Global Anti Peptic Ulcer Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Global Anti Peptic Ulcer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Anti Peptic Ulcer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Anti Peptic Ulcer Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 75. Global Anti Peptic Ulcer Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 76. North America Anti Peptic Ulcer Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. North America Anti Peptic Ulcer Drugs Sales by Country (2021-2026) & (K Units)
Table 78. North America Anti Peptic Ulcer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Anti Peptic Ulcer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Anti Peptic Ulcer Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. North America Anti Peptic Ulcer Drugs Sales by Type (2021-2026) & (K Units)
Table 82. North America Anti Peptic Ulcer Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. North America Anti Peptic Ulcer Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Europe Anti Peptic Ulcer Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Anti Peptic Ulcer Drugs Sales by Country (2021-2026) & (K Units)
Table 86. Europe Anti Peptic Ulcer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Anti Peptic Ulcer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Anti Peptic Ulcer Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Anti Peptic Ulcer Drugs Sales by Type (2021-2026) & (K Units)
Table 90. Europe Anti Peptic Ulcer Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Anti Peptic Ulcer Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Anti Peptic Ulcer Drugs Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Anti Peptic Ulcer Drugs Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Anti Peptic Ulcer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Anti Peptic Ulcer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Anti Peptic Ulcer Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Anti Peptic Ulcer Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Anti Peptic Ulcer Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Anti Peptic Ulcer Drugs Sales by Application (2021-2026) & (K Units)
Table 100. South America Anti Peptic Ulcer Drugs Sales by Country (2016-2021e) & (K Units)
Table 101. South America Anti Peptic Ulcer Drugs Sales by Country (2021-2026) & (K Units)
Table 102. South America Anti Peptic Ulcer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Anti Peptic Ulcer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Anti Peptic Ulcer Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. South America Anti Peptic Ulcer Drugs Sales by Type (2021-2026) & (K Units)
Table 106. South America Anti Peptic Ulcer Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. South America Anti Peptic Ulcer Drugs Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Anti Peptic Ulcer Drugs Typical Distributors
Table 119. Anti Peptic Ulcer Drugs Typical Customers
List of Figures
Figure 1. Anti Peptic Ulcer Drugs Picture
Figure 2. Global Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 3. Proton Pump Inhibitors (PPIs)
Figure 4. Potassium-Competitive Acid Blockers (P-CAB)
Figure 5. Antacids
Figure 6. H2 Antagonists
Figure 7. Antibiotics
Figure 8. Ulcer Protective Drugs
Figure 9. Global Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 10. Gastritis
Figure 11. Gastric Ulcers
Figure 12. Duodenal Ulcers
Figure 13. Gastroesophageal Reflux Disease (GERD)
Figure 14. Global Anti Peptic Ulcer Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Anti Peptic Ulcer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Anti Peptic Ulcer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Anti Peptic Ulcer Drugs Sales (2016-2026) & (K Units)
Figure 36. Global Anti Peptic Ulcer Drugs Production Capacity (2016-2026) & (K Units)
Figure 37. Global Anti Peptic Ulcer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Anti Peptic Ulcer Drugs Market Drivers
Figure 39. Anti Peptic Ulcer Drugs Market Restraints
Figure 40. Anti Peptic Ulcer Drugs Market Trends
Figure 41. Global Anti Peptic Ulcer Drugs Sales Market Share by Manufacturer in 2020
Figure 42. Global Anti Peptic Ulcer Drugs Revenue Market Share by Manufacturer in 2020
Figure 43. Anti Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Anti Peptic Ulcer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Anti Peptic Ulcer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Anti Peptic Ulcer Drugs Sales Market Share by Region (2016-2026)
Figure 47. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region (2016-2026)
Figure 48. North America Anti Peptic Ulcer Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Europe Anti Peptic Ulcer Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Anti Peptic Ulcer Drugs Revenue (2016-2026) & (USD Million)
Figure 51. South America Anti Peptic Ulcer Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Anti Peptic Ulcer Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2026)
Figure 54. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2016-2026)
Figure 55. Global Anti Peptic Ulcer Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 56. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2026)
Figure 57. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2016-2026)
Figure 58. Global Anti Peptic Ulcer Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 59. North America Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2026)
Figure 60. North America Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2026)
Figure 61. North America Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2026)
Figure 62. North America Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2026)
Figure 63. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2026)
Figure 64. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Europe Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2026)
Figure 66. Europe Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Anti Peptic Ulcer Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Anti Peptic Ulcer Drugs Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Anti Peptic Ulcer Drugs Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2026)
Figure 72. South America Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2026)
Figure 73. South America Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2026)
Figure 74. South America Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
消化性潰瘍薬の世界市場2018-2025 Drug treatment of peptic ulcers is targeted at either counteracting aggressive factors or stimulating the mucosal defense.Drugs that inhibit or neutralize gastric acid secretion include histamine H2-receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandins and antacids. In 2018,…- 世界の抗にきび薬市場 2021：企業別、地域別、種類・用途別 The Anti Acne Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 世界の抗片頭痛薬市場 2021：企業別、地域別、種類・用途別 The Anti-Migraine Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 抗肥満薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain diet…
- 抗出血薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 This reprot mainly studies Anti-bleeding Drugs market, Anti-bleeding Drugs are drugs that prevent or reduce coagulation of blood, prolonging the clotting time. Scope of the Report: This report focuses on the Anti-bleeding Drugs in global market, especially in North America, Europe and Asia-Pacific, …